Drug can Prevent Postpartum Hemorrhage

By  ,  National Institute of Health
Feb 11, 2015

Subscribe for daily wellness inspiration

Like onlymyhealth on Facebook!

Quick Bites

  • Postpartum hemorrhage can be fatal when birth occurs at home.
  • Condition occurs when uterus fails to contract,
  • Oxytocin is a standard drug to prevent postpartum hemorrhage.
  • Drug misoprostol can stop uterine bleeding.

Deaths from postpartum hemorrhage, excessive bleeding by the mother after giving birth, are rare in developed countries like the U.S.  However, the condition can be life-threatening in places where most births occur at home and emergency care may not be available.  Researchers have now found a safe, convenient and inexpensive way to prevent this major killer of women in developing countries.

Drug for Postpartum Hemorrhage

Causes of Postpartum Hemorrhage

Postpartum hemorrhage is caused by the uterus failing to contract after the placenta detaches, or by ruptures or tears in the uterus and other tissues.  In developed countries, oxytocin is the standard drug used to prevent postpartum hemorrhage.  But oxytocin needs to be kept cold and to be given by trained medical personnel, so it’s not ideal for use in developing countries.

The Research

The drug misoprostol also stops uterine bleeding, but doesn’t require refrigeration and doesn’t have to be given by highly trained personnel.  Researchers from the University of Missouri, India’s Jawaharlal Nehru Medical College and NIH set out to test whether this inexpensive drug could effectively prevent postpartum hemorrhage in countries where hospital services are in limited supply.

Drug for Postpartum Hemorrhage

The researchers recruited 25 nurse midwives who serve the rural Indian villages of the Belgaum District in Karnataka State.  They showed the midwives how to use misoprostol and how to measure blood loss following birth using a plastic drape specifically designed for the study.  Women who volunteered to participate received either misoprostol or an identical-looking but inactive “placebo” immediately after they gave birth.

The Findings

While 12% of the women in the placebo group had serious postpartum hemorrhage, only 6.4% receiving misoprostol did.  Women receiving misoprostol also lost significantly less blood on average.  Side effects included a slight increase in shivering and fever.  The infants of nursing mothers who took misoprostol showed no apparent side effects.

Another benefit from the study was the development of the drape to estimate blood loss.  Before this trial, the midwives had no way to accurately gauge blood loss.  The drape provided an accurate, easy-to-use and inexpensive (about $1 each) way to collect and measure blood.  Wider use of it could lead to earlier detection of postpartum hemorrhage and earlier interventions to save lives.

Image courtesy: Getty Images

Read more articles on Childbirth (Delivery).

Write Comment Read ReviewDisclaimer
Is it Helpful Article?YES41796 Views 0 Comment